Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release
about
High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting MechanismsMicroparticles: markers and mediators of sepsis-induced microvascular dysfunction, immunosuppression, and AKIThe role of the Hsp90/Akt pathway in myocardial calpain-induced caspase-3 activation and apoptosis during sepsis.Activation of Both the Calpain and Ubiquitin-Proteasome Systems Contributes to Septic Cardiomyopathy through Dystrophin Loss/Disruption and mTOR InhibitionHeat stress prevents lipopolysaccharide-induced apoptosis in pulmonary microvascular endothelial cells by blocking calpain/p38 MAPK signallingCritical role of calpain in inflammationGenipin alleviates sepsis-induced liver injury by restoring autophagyUpdate in sepsis 2012.The emerging roles of microvesicles in liver diseases.Extracellular Vesicles in Renal Pathophysiology.Extracellular vesicles in renal disease.Specific calpain inhibition protects kidney against inflammaging.Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy.Calpains promote neutrophil recruitment and bacterial clearance in an acute bacterial peritonitis model.Recent advances in the pathogenetic mechanisms of sepsis-associated acute kidney injury.Caspase-11-mediated endothelial pyroptosis underlies endotoxemia-induced lung injury.Role of extracellular vesicles in the development of sepsis-induced coagulopathyOverexpression of homeodomain-interacting protein kinase 2 (HIPK2) attenuates sepsis-mediated liver injury by restoring autophagy
P2860
Q26774658-FF664687-04D8-4CF5-8522-B4EEB725169CQ27694575-0F8E5652-210C-4F52-AF5F-E4F355F9EA5BQ34593335-B844869A-B6BF-4FD3-9770-01E7A843F8BAQ36202683-1EA7D770-AFB1-45D4-A6BF-4518FDCA4F16Q37348219-03FB3734-7273-48D3-8270-AB57A4AFCC86Q37581981-41027EC4-DDD4-449B-86B8-68794795AFB8Q37686132-4DE9D1A9-2D5D-4F31-8292-14B0CCA22D9DQ38114486-2839A3D7-AD68-4063-9155-00597893D4B1Q38184831-D3B4E460-586C-49DF-BC38-B27B6C36218DQ39389732-6B284D3F-D602-4633-8403-0B122B9EAD91Q39453434-83DA463E-2664-44AA-ACD4-427BC9B8672CQ41387378-70DB131F-405E-4A86-ACAD-8C7AE548647CQ46328110-C1B1ADAF-8707-4032-A9B5-482D4B57710DQ46953289-8C087F2D-BA13-48AB-8F00-241F67F86544Q47255833-DD3A140F-EB32-4604-A7AC-096DB35157D5Q47678443-E19D210B-EEA1-4313-8DA2-DB63F7639916Q58121058-8CFA425F-07F1-422E-BA0C-B5618E929779Q58699616-64DB5A63-7A37-454D-94DD-7EF79D50A154
P2860
Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release
@ast
Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release
@en
type
label
Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release
@ast
Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release
@en
prefLabel
Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release
@ast
Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release
@en
P2093
P2860
P1476
Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release
@en
P2093
Asada Leelahavanichkul
Charlène Lévi
Colleen Byrnes
Emmanuel Letavernier
Grigoris Gerotziafas
Ismail Elalamy
Jean-philippe Haymann
Jeffrey L Miller
Joelle Perez
Lara Zafrani
P2860
P304
P356
10.1164/RCCM.201109-1686OC
P407
P50
P577
2012-01-20T00:00:00Z